Health Care & Life Sciences » Pharmaceuticals | Daesung Microbiological Laboratories Co. Ltd.

Daesung Microbiological Laboratories Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
433
2,042
4,550
4,495
1,558
Depreciation, Depletion & Amortization
1,308
1,360
1,389
1,364
985
Other Funds
849
529
899
94
286
Funds from Operations
2,590
3,931
6,838
5,953
2,828
Changes in Working Capital
700
97
824
2,432
1,147
Net Operating Cash Flow
1,890
3,834
7,663
3,521
1,681
Capital Expenditures
3,016
863
875
948
1,273
Sale of Fixed Assets & Businesses
10
34
25
23
12
Purchase/Sale of Investments
173
233
466
3,787
1,350
Net Investing Cash Flow
2,833
1,061
1,316
4,717
89
Cash Dividends Paid - Total
323
323
323
380
380
Issuance/Reduction of Debt, Net
1,333
2,381
1,000
573
223
Net Financing Cash Flow
1,010
2,704
1,323
953
603
Net Change in Cash
53
64
5,102
2,078
803
Free Cash Flow
987
3,006
7,104
2,913
552
Exchange Rate Effect
14
5
79
72
364
Other Uses
-
-
-
5
-

About Daesung Microbiological Laboratories Co.

View Profile
Address
103 Deogyeong-daero
Uiwang GY 16103
Korea, Republic Of
Employees -
Website http://www.dsmbio.com
Updated 09/14/2018
DAESUNG MICROBIOLOGICAL LABORATORIES Co., Ltd. engages in the manufacture and sale of veterinary drugs. Its products include antibiotics, antibacterials, mastitis ointments, anthelmintics, disinfectants, probiotics, enzyme products, teat dipping disinfectants, metabolites, nutrients, biologicals for cattle, swine poultry and canine. The company was founded on May 11, 1968 and is headquartered in Uiwang, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.